Overall Technical outlook

Price Summary

On 2026-02-02, Aurobindo Pharma Limited's stock began at 1172.1, peaked at 1185.0, bottomed at 1152.3, and closed -0.09% lower at 1171.0, with a volume of 768237 shares.
During the 52-week span, the stock hit a high of 1257.8 and a low of 1022.2.
The projected price range for Aurobindo Pharma Limited is between 730.0 and 1640.0, with an expected mean price of 1311.2069, according to 29 analysts.

Technicals

Support and Resistance: At 1171.0, the price is supported at 1158.6 and faces resistance at 1194.0. This range suggests that the price for AUROPHARMA might stay between these levels, with 1158.6 acting as a floor and 1194.0 as a ceiling.
AUROPHARMA supportResistance 8a09da
Support/Resistance for AUROPHARMA


Aroon: The AROON is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
AUROPHARMA aroon 8a09da
Aroon chart for Aurobindo Pharma Limited


Bol. Bands: The current reading of the BOLL BANDS indicator suggests a neutral stance, with no clear signals indicating an upward or downward direction. This lack of directional bias suggests the market may be in a period of consolidation or uncertainty.
AUROPHARMA bbands 8a09da
Bolinger Bands chart for Aurobindo Pharma Limited


Parabolic SAR: The PSAR remains bullish, reinforcing a significant support level. This steady support suggests that the market's upward trend may continue, providing a solid foundation for potential gains for AUROPHARMA. Investors might see this as an opportunity to capitalize on the ongoing bullish sentiment.
AUROPHARMA psar 8a09da
Parabolic Stop and Reverse chart for Aurobindo Pharma Limited


Stochastic: The STOCHASTIC is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
AUROPHARMA stoch 8a09da
Stochastic chart for Aurobindo Pharma Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG is neutral for AUROPHARMA, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
AUROPHARMA trippleSMA 8a09da
Tripple SMA chart for Aurobindo Pharma Limited


When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.